Gender-Specific Phase III Trial For Advanced Non-Small Cell Lung Cancer Approved
Cell Therapeutics has begun a confirmatory phase III clinical trial of combination chemotherapy for women with advanced non-small cell lung cancer.
|
Giving Patients A Fighting Chance Against Lung Cancer
While cure rates for many other types of lung cancer have improved, progress in the early detection and treatment of lung cancer is barely moving forward.
|
Lilly's ALIMTA Treats Non-Small Cell Lung Cancer
Eli Lilly and Company has submitted an application with EMEA for review of ALIMTA, in combination with cisplatin, for the first-line treatment of advanced non-small cell lung cancer.
|
Radon - Natural But Nevertheless A Health Hazard
Prolonged exposure to high levels of Radon is a health hazard and can increase the risk of lung cancer.
|
ERBITUX Increases Survival In Phase III Lung Cancer Study
Phase III study of ERBITUX in combination with platinum-based chemotherapy met its primary endpoint of increasing overall survival compared with chemotherapy alone in patients with advanced non-small cell lung cancer.
|
XL647 As First-Line Therapy For Non-Small Cell Lung Cancer Is Encouraging
Exelixis reported interim data from an ongoing phase 2 trial evaluating XL647 as first-line therapy for patients with non-small cell lung cancer (NSCLC).
|
International Investigators Studying Lung Cancer
Lung Cancer Alliance shows significant development in how doctors and patients will more precisely stage, diagnose and treat lung cancer.
|
Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer
Study in a lung cancer model shows the combination of a mouse equivalent of bavituximab and radiation is significantly more effective in reducing tumor growth than either therapy alone.
|
Knee arthritis my be the first symptom of lung cancer
Arthritis of the knee may be the first symptom of a type of lung cancer that is hard to treat in heavy smokers
|
ONCONASE Enhances Effect Of Radiation In Non-Small Cell Lung Cancer
ONCONASE significantly enhances the effect of the radiation response in human non-small cell lung cancer (NSCLC) in vitro and in vivo.
|
Picoplatin Phase 2 Small Cell Lung Cancer Trial Promising
Poniard Pharmaceuticals will present updated results from its Phase 2 trial of picoplatin for lung cancer treatment.
|
Cranial irradiation in small cell lung cancer increases survival
Study results may change medical practice on lung cancer treatment in USA and Europe.
|
Senate Reiterates Calls For Making Lung Cancer Research National Priority
U.S. Senate unanimously reconfirmed its commitment to making lung cancer research a national public health priority.
|
New lung tumor-suppressor gene blocks lung cancer process
Scientists have found that a particular gene can block key steps of the lung cancer process in mice.
|
Defects in critical gene lead to accelerated lung tumor growth
Scientists have added to the list another powerful tumor suppressor, a gene called LKB1. Their research indicates that this gene is mutated in almost a quarter of all human lung cancers.
|
PET Scan Shows If Radiation Is Shrinking Lung Tumor
Lung cancer patients may not need to wait till their radiation treatment is over to know if it worked.
|
FDA Approves Lymph Node Test For Breast Cancer Patients
FDA approved Johnson & Johnson subsidiary Veridex's test called GeneSearch Breast Lymph Node Assay.
|
Peregrine Pharmaceuticals To Initiate Bavituximab Phase II Trial In Lung Cancer Patients
Peregrine Pharmaceuticals to conduct Phase II trial of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer.
|
FDA Reviews HYCAMTIN To Treat Relapsed Small Cell Lung Cancer
GlaxoSmithKline's new drug application for ORAL HYCAMTIN capsules, a treatment for relapsed small cell lung cancer, has been granted Priority Review by the United States Food and Drug Administration.
|
Genomic Signatures Identify Targeted Therapies For Lung Cancer
Any number of things can go wrong in the cells of the body to cause cancer -- and clinicians can't tell by just looking at a tumor what exactly triggered the once normal cells to turn cancerous.
|
Pharmacyclics Announces Positive Final Results Of Phase 2 Trial Of Xcytrin Plus Radiosurgery
Final results from an open-label multi-center Phase 2 clinical trial indicated that Xcytrin Injection may improve the efficacy of stereotactic radiosurgery.
|
Poniard's Phase 2 Trial Confirms Survival Benefit In Small Cell Lung Cancer
Picoplatin results confirm data analysis from the Company's Phase 2 clinical trial, which demonstrated a survival benefit in patients with recurrent small cell lung cancer (SCLC).
|
Encouraging Survival Results For Phase I/II Trial Of OGX-011 In Non-Small Cell Lung Cancer
OncoGenex Technologies and Isis Pharmaceuticals announced encouraging preliminary data from a Phase I/II clinical trial of OGX-011 in first-line combination therapy for advanced non-small cell lung cancer.
|
SUTENT, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer
Pfizer says clinical trials examining its different cancer-fighting approaches showed activity in patients with non-small cell lung cancer (NSCLC).
|
Avastin Plus Chemotherapy May Help Non-Small Cell Lung Cancer
Genentech today announced that a Roche-sponsored, randomized placebo controlled Phase III clinical study (AVAiL) demonstrated that Avastin (bevacizumab), studied at two different doses in combination with gemcitabine and cisplatin chemotherapy, significantly increased the time patients with advanced non-small cell lung cancer (NSCLC) lived without their disease advancing, as defined by progression-free survival (PFS).
|
Avastin Significantly Prolongs Survival of Advanced Lung Cancer Patients
Only First-line Treatment of Lung Cancer with Avastin to Demonstrate Extended Survival in Over a Decade.
|
Lilly Studies Try To Shed Light On Impact Of Race On Lung Cancer Treatment
Lung cancer is the leading cause of cancer death in African-Americans, with 21,550 new cases expected to be diagnosed and 16,700 deaths expected this year.
|
Edward Cancer Center Treats Lung Cancer With Novel Adaptive Image-Guided Radiotherapy
Clinicians at Edward Hospital here are using Trilogy technology from Varian Medical Systems to offer some cancer patients a novel treatment that adapts to changes in the tumor so that more healthy tissue can be preserved.
|
Poniard To Presents Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial
Poniard Pharmaceuticals announced that data from a Phase 2 trial of picoplatin in patients with small cell lung cancer will be presented in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology.
|
FDA Filing Of New Drug Application For Xcytrin Injection To Treat Lung Cancer Brain Metastases
The Company is seeking approval to market the drug for the treatment of non-small cell lung cancer patients with brain metastases
|
Minimally Invasive Lung Cancer Surgery Can Improve Chemotherapy Outcomes
Patients who undergo a minimally invasive lung cancer surgery called thoracoscopic lobectomy may derive more benefit from the chemotherapy that follows
|
Immunosuppressant Drug Prevents Tobacco Induced Lung Cancer In Mice
Rapamycin, an FDA-approved drug was highly effective in preventing the development of tobacco-related lung tumors in mice.
|
Lung Cancer Study Aims to Identify Early Detection and Prevention Method
Lung cancer is one of the only common cancers without a standardized method for early detection and prevention.
|
Radiofrequency ablation effective for treating lung cancer treatment
A minimally invasive procedure known as radiofrequency ablation is effective for lung cancer treatment in patients who are not candidates for surgery.
|
Lack of a Protein in Lung Tumors May Increase Risk of Death
Lung cancer patients who lack a particular protein may do more poorly after surgery than those with normal levels of that same protein.
|
Chemotherapy Resistance Testing in Lung Cancer Patients Needs to Be Studied
Oncologists should take more advantage of laboratory tests that have the potential to help determine a lung cancer patient's resistance to chemotherapy drugs.
|
Video Assisted Lung Surgery Gets Patients Back on their Feet Faster, with Less Pain
Just a few days after lung cancer surgery, Louise Dellert was thrilled and surprised to be up doing dishes and setting the table.
|
Blood pressure drug shows potential as lung cancer treatment
A hormone that is important in the control of blood pressure also treats lung cancer tumors in mice.
|
Researchers Identify Biomarker for Lung Cancer Signs
Researchers a gene expression marker that distinguishes smokers with lung cancer signs from smokers without the disease.
|
Minimally Invasive Procedure Effectively Detects and Evaluates Lung Cancer
Endoscopic ultrasound can safely and effectively determine whether masses in or around the lungs are cancerous or benign.
|
